22 March 2022 - final results
The AIM-listed healthcare group has announced its annual results for the year to 31 December 2021 and these have shown further impressive growth. Revenues for the year rose by 26% to £163.2m (2020: £129.8m) with underlying pre-tax profits rising by the same amount to £42.2m (2020: £33.5m). Earnings per share on the same basis were 25% higher at 6.39p (2020: 5.11p) and the dividend has been raised by just 5% to 1.69p (2020: 1.61p). Strong cash flow from operations has meant that net debt has . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
